A review argues combined hepatitis B marker panels predict sustained surface-antigen loss better than single tests, while reporting no numerical results anywhere in the release.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.